Larimer et al. first established in a syngeneic murine model of colon adenocarcinoma that the elevation of granzyme B seen in immunoblot and immunohistochemical studies was demonstrated on PET imaging using the novel granzyme B PET (GZP) agent that they developed [18]. The gene discussed is GZMB; the disease is colon adenocarcinoma.